LC-HRMS Metabolomics Profiling in Advanced NSCLC Treated with Anti PD-1 Agents. Metabolic Features at Diagnosis and at Response Evaluation

被引:0
作者
Ortega Granados, A. L. [1 ]
Garcia Verdejo, F. J. [1 ]
Cardenas Quesada, N. [1 ]
Ruiz Sanjuan, M. [1 ]
Diaz Navarro, C. [2 ]
De La Torre Cabrera, C. [1 ]
Fernandez Navarro, M. [1 ]
Perez Chica, G. [3 ]
Vicente Perez, F. [2 ]
Moreno Jimenez, M. A. [1 ]
Luque Caro, N. [1 ]
Marquez Lobo, B. [4 ]
Jaen Morago, A. [1 ]
Duenas Garcia, R. [1 ]
Martinez Ortega, E. [1 ]
Sanchez Rovira, P. [1 ]
Perez Del Palacio, J. [2 ]
机构
[1] Complejo Hosp Jaen, Oncol Med, Jaen, Spain
[2] Fdn Medina, Granada, Spain
[3] Complejo Hosp Jaen, Neumol, Jaen, Spain
[4] Complejo Hosp Jaen, Anat Patol, Jaen, Spain
关键词
metabolomics; anti PD-1; biomarker;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.07-036
引用
收藏
页码:S2008 / S2009
页数:2
相关论文
empty
未找到相关数据